Poliomyelitis Clinical Trials

Find Poliomyelitis Clinical Trials Near You

A Phase 1, Double-blinded, Randomised, Active Controlled, Clinical Trial to Assess the Reactogenicity, Safety and Immunogenicity of a Recombinant Poliomyelitis Vaccine (rPV) in Comparison With IPOL Vaccine in Healthy Adults

Status: Recruiting
Location: See location...
Intervention Type: Biological
Study Type: Interventional
Study Phase: Phase 1
SUMMARY

The primary purpose of this study is to test a new experimental recombinant Poliomyelitis vaccine (rPV) in comparison to the commercially available inactivated poliovirus vaccine. The design of the study is double-blinded, randomised and active controlled. The active controlled product is considered the commercially available vaccine (IPOL).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 60
Healthy Volunteers: t
View:

• Healthy Volunteers aged between 18 to 60 years inclusive.

• Good physical and mental health based on medical history, physical examination, clinical laboratory,electrocardiogram (ECG), and vital signs, as judged by the Investigator.

• Participants must refrain from strenuous exercise within 96 hours (4 days) prior to Screening, Day 1, Day 8,and Day 30..

• Willing and able to comply with restrictions of nicotine (i.e., tobacco and nicotine products) usethroughout the study is not permitted from within 48 hours (2 days) prior to Screening, from Day 1 until Day8, and within 48 hours (2 days) prior to the end of study visit.

• Participants must agree to use highly effective contraception from Day 1 until 90 days after the last studyvisit.

Locations
Other Locations
Australia
Doherty Clinical Trials Limited
RECRUITING
East Melbourne
Contact Information
Primary
Dr Hitt Sharma, MBBS MBA
drhjs@seruminstitute.com
+91-9822418354
Backup
Dr Sameer Parekh, MBA
sameer.parekh@seruminstitute.com
+91-9226722745
Time Frame
Start Date: 2026-09-11
Estimated Completion Date: 2027-03
Participants
Target number of participants: 36
Treatments
Experimental: Recombinant Poliomyelitis Vaccine (rPV)
Active_comparator: Inactivated Poliomyelitis Vaccine (IPOL)
Related Therapeutic Areas
Sponsors
Leads: Serum Institute of India Pvt. Ltd.

This content was sourced from clinicaltrials.gov

Similar Clinical Trials